TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | -2 | -4 | 52 | 62 | 70 | 0 | 36 |
| P | %wins | 0 | 0 | 100 | 100 | 100 | 60 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/14/17 17:05 | 11/14/17 | PRTO | Proteon Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Eldridge, George Arthur | MA | O | SVP,CFO, | P | 0 | 1.69 | 0 | 0 | 2 | 14 | I | ||||||||||||||
6/7/16 07:49 | 6/6/16 | PRTO | Proteon Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Eldridge, George Arthur | MA | O | SVP,CFO, | P | 23 | 5.78 | 0 | 4 | 3 | M | -65 | -61 | -11 | -42 | -26 | -17 | -9 | -2 | -4 | 52 | 62 | 70 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |